Sunrise’s Post

[Event 📣] Join Dr. Martinot at #Sleep2024 to discuss the latest advancements in MAD therapy. 🦷 Poster #381 Oral Appliance Therapy for Obstructive Sleep Apnea: Dose-Response Relationship Between Mandibular Protrusion and Improvement in Respiratory Effort Burden. 🔎 About the Study This study unveils a tailored approach to managing Obstructive Sleep Apnea (OSA). Using innovative jaw movement monitoring technology, the research followed 93 patients through the process of adjusting their MADs to find the best position that reduces the Respiratory Effort Burden as measured with mandibular jaw movements (REMOV). ⭐K️ey findings The results showed a clear dose-response effect: as the MAD was advanced, patients experienced significant reductions in REMOV. This finding suggests monitoring REMOV along with other metrics via at-home MJM analysis allows for identifying the optimal advancement level during MAD titration. This approach would enhance the treatment efficacy by enabling personalized adjustments based on multiple physiological outcomes. Join Dr. Martinot on Tuesday, June 4, 2024, Poster #381 to learn more! #Sleep2024 #OSAResearch #SleepApnea #MandibularAdvancement #SunriseSleepScience

🚀 Countdown to Poster Presentation at #Sleep2024! 📢 As we gear up for a detailed discussion with Dr. Martinot, we invite you to revisit this study on Oral Appliance Therapy titration using unique insights from Mandibular Jaw Movements automated analysis. 👨🔬 Join Dr. Martinot, on June 4th, at Poster #381 to discover how this dose-response effect could impact the management of Obstructive Sleep Apnea by enabling more personalized treatment strategies. https://lnkd.in/eTCRqjCv

🚀 Countdown to Poster Presentation at #Sleep2024! 📢 As we gear up for a detailed discussion with Dr. Martinot, we invite you to revisit this study on Oral Appliance Therapy titration using unique insights from Mandibular Jaw Movements automated analysis. 👨🔬 Join Dr. Martinot, on June 4th, at Poster #381 to discover how this dose-response effect could impact the management of Obstructive Sleep Apnea by enabling more personalized treatment strategies. https://lnkd.in/e9CXhvp3

"There is an unexpected high prevalence of SDB in patients with symptomatic CHF, despite state of the art heart failure medication..." Unfortunately, there is an often-overlooked connection between sleep-disordered breathing (SDB) and chronic heart failure (CHF). Here are some highlights from the study: 1. About 75% of CHF patients in the study had some form of sleep apnoea, with 40% having central sleep apnoea (CSA) and 36% obstructive sleep apnoea (OSA). 2. Patients with CSA showed more advanced symptoms of heart failure, including lower left ventricular ejection fraction and larger left atrial diameters. 3. The presence of a higher Apnea-Hypopnea Index (AHI) in CHF patients has been identified as a powerful predictor for poor prognosis, emphasizing the importance of addressing sleep apnoea in these patients. Download this study from this post! Dentists, you can leverage this study to educate medical professionals about the critical link between sleep apnoea and heart failure. Position yourself as a valuable partner in a multidisciplinary approach to patient care. If you need help figuring out how to share this info with your local MDs, send us a message we will help you build a custom plan for your sleep practice! #Dental #DentalSleepMedicine #OSA

𝐒𝐨𝐦𝐧𝐨𝐃𝐞𝐧𝐭 𝐀𝐯𝐚𝐧𝐭: 𝐆𝐫𝐞𝐚𝐭𝐞𝐫 𝐞𝐟𝐟𝐢𝐜𝐚𝐜𝐲 𝐭𝐡𝐚𝐧 𝐰𝐢𝐧𝐠-𝐛𝐚𝐬𝐞𝐝 𝐝𝐞𝐯𝐢𝐜𝐞𝐬¹ Studies with wing-based devices have typically reported treatment success as AHI < 10 and 50% reduction in AHI.² SomnoDent Avant delivers an AHI of 6.1 with 70% AHI reduction in moderate-severe OSA patients. Read the research paper here: https://lnkd.in/dsEbA8kw #SomnoMed #SomnnoDentAvant #OSAPatients #sleep #sleepapnea ¹ Vanderveken OM, Van Daele M, Verbraecken J, Braem MJ, Dieltjens M. Comparative analysis of two custom-made mandibular advancement devices with varied designs for treating moderate to severe obstructive sleep apnea. Sleep Med. 2024 May;117:95-98. doi: 10.1016/j.sleep.2024.02.035. Epub 2024 Mar 7. PMID: 38518588. ² Shi, X., Lobbezoo, F., Chen, H. et al. Comparisons of the effects of two types of titratable mandibular advancement devices on respiratory parameters and upper airway dimensions in patients with obstructive sleep apnea: a randomized controlled trial. Clin Oral Invest 27, 2013–2025 (2023). https://lnkd.in/d57SyYab

𝐒𝐨𝐦𝐧𝐨𝐃𝐞𝐧𝐭 𝐀𝐯𝐚𝐧𝐭 : 𝐀 𝐧𝐞𝐰 𝐜𝐥𝐚𝐬𝐬 𝐢𝐧 𝐎𝐀𝐓 𝐞𝐟𝐟𝐞𝐜𝐭𝐢𝐯𝐞𝐧𝐞𝐬𝐬¹ Unlike other studies not finding significant differences between MAD designs²,³, SomnoDent Avant with passive mouth closing shows significantly better AHI reduction compared with the traditional wing-based design. Read the research paper here: https://lnkd.in/dsEbA8kw #SomnoMed #SomnnoDentAvant #OSAPatients ¹ Vanderveken OM, Van Daele M, Verbraecken J, Braem MJ, Dieltjens M. Comparative analysis of two custom-made mandibular advancement devices with varied designs for treating moderate to severe obstructive sleep apnea. Sleep Med. 2024 May;117:95-98. doi: 10.1016/j.sleep.2024.02.035. Epub 2024 Mar 7. PMID: 38518588. ² Shi X, Lobbezoo F, Chen H, et al. Comparisons of the effects of two types of titratable mandibular advancement devices on respiratory parameters and upper airway dimensions in patients with obstructive sleep apnea: a randomized controlled trial. Clin Oral Invest 2023;27:2013–25. ³ Verburg FE, Bollen KHA, Donker HJ, Kramer GJC. The effectiveness of two types of MADS for OSA therapy. Clin Oral Invest 2018;22:1995–2003.

Join ProSomnus® Sleep Technologies for a live 60-minute webinar on Friday, September 6th @ 9:00am Pacific Time (6:00pm CEST) for an encore presentation of Prof. Dr. Marc Braem ProSleep 2024 lecture, “Learnings from a Multicenter Retrospective Study with ProSomnus® EVO®” as well as a company update from #team #ProSomnus. 📍 ProSleep 2024 Encore Presentation & Company Update 🗣️ Prof. Dr. Marc Braem, DDS, PhD 🗓️ Friday, September 6, 2024 | 9:00am Pacific Time (6:00pm CEST) Learnings from a Multicenter Retrospective Study with ProSomnus® EVO® • Can an Oral Appliance Therapy protocol implemented across six hospitals yield consistent, efficacious, outcomes for patients with moderate and severe OSA? • What was the protocol for taking the construction bite and titration? ProSomnus Programming • End of Year Cutoff Date Announcement • 3-Year Continuous Therapy Report Register via the link or scan the QR code: https://loom.ly/pERMPZU #ProSomnus #OSA #SleepEducation #SleepResearch #SleepMedicine #SleepProviders #SleepChamps

Unlock the hidden burden of Obstructive Sleep Apnea with Dr. Bandana Mishra - Head of the Department and Senior Consultant in Pulmonology at Sanar International Hospitals! Dive into the depths of OSA – its causes, risks, and treatment options in our latest video. Learn about the serious health implications linked to OSA, including heightened stroke and heart risk. Dr. Mishra sheds light on diagnosis methods like polysomnography and the transformative impact of CPAP therapy. Plus, gain valuable insights on preventive techniques by maintaining a healthy lifestyle. Whether you're a patient, caregiver, or simply curious about sleep health, this video is a must-watch! Stay tuned for more enlightening updates! Have questions or topics you want us to explore? Drop them in the comments below! Call now for more information: +91 9986611399 #sleephealth #OSAawareness #CPAPtherapy #healthyliving #SanarHospital #DrBandanaMishra

Dr. Shamil PK, our esteemed Specialist Interventional Pulmonologist, Critical Care & Sleep Medicine expert, has just had his insightful article on the JN.1 Variant published in The Daily Tribune newspaper! His expertise sheds light on crucial concerns surrounding this variant, offering valuable insights into its implications. Stay informed and updated on the latest in pulmonology, critical care, and sleep medicine by checking out this insightful article in The Daily Tribune. @newsofbahrain_ #pulmonology #JN1Variant #Pulmonology #CriticalCare #SleepMedicine #ExpertOpinion #TheDailyTribune #HealthcareExcellence #bah #bahrain #bahrainnews

Usama Kanaan, M.D. and Erik Michelfelder, M.D. participated in a study to examine the prevalence of pulmonary hypertension (PHTN) in children with obstructive sleep apnea (OSA) using echocardiographic (ECHO) parameters and to examine ECHO findings as they relate to severity of OSA. To read more: https://bit.ly/4bLwHd5 Milligan I, Shaw AK, Leu R, Kanaan U, Michelfelder E. Prevalence of pulmonary hypertension in obstructive sleep apnea and its relation to disease severity. J Clin Sleep Med. 2024 May 1;20(5):675-680. doi: 10.5664/jcsm.10952. PMID: 38078676; PMCID: PMC11063703.